5 Key Takeaways

• 1

  Pseudaminic acid, a bacterial sugar, may help expose drug-resistant pathogens to the immune system.

• 2

  Monoclonal antibodies targeting pseudaminic acid can recognize multiple pathogenic species and eliminate infections in mice.

• 3

  Researchers developed synthetic glycopeptides to create pan-specific antibodies that bind various forms of pseudaminic acid.

• 4

  The study established a glycoproteomic workflow to map pseudaminic acid in key pathogens like Helicobacter pylori.

• 5

  The findings suggest potential for new passive immunotherapies against multidrug-resistant Acinetobacter baumannii.